Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Jun 27, 2024; 16(6): 1756-1764
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1756
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1756
Table 4 Comparison of complication rates between the two groups, n (%)
| Index | TACE + RFA group (n = 45) | RFA group (n = 45) | χ2 | P value |
| Fever | 3 | 2 | ||
| Bleeding | 1 | 1 | ||
| Liver abscess | 1 | 0 | ||
| Nausea and vomiting | 1 | 1 | ||
| Upper gastrointestinal bleeding | 1 | 0 | ||
| Abdominal pain | 1 | 1 | ||
| Abnormal liver function | 4 | 3 | ||
| Total incidence rate | 12 (26.67) | 8 (17.78) | 2.286 | 0.131 |
- Citation: Guo JY, Zhao LL, Cai HJ, Zeng H, Mei WD. Radiofrequency ablation combined with transcatheter arterial chemoembolization for recurrent liver cancer. World J Gastrointest Surg 2024; 16(6): 1756-1764
- URL: https://www.wjgnet.com/1948-9366/full/v16/i6/1756.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i6.1756